Search research articles
Contact Us
Filters
Showing results (571-580 of 731) with videos related to
Page
of 74
Sort By:
Plos One
|
May 19, 2016
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial
Agricola Joachim, Asli Bauer, Sarah Joseph, et al.
Plos Pathogens
|
August 4, 2016
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection
Korey R Demers, George Makedonas, Marcus Buggert, et al.
The Journal of Infectious Diseases
|
October 29, 2002
Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells
Mary A Marovich, John R Mascola, Michael A Eller, et al.
AIDS Research and Human Retroviruses
|
August 12, 2003
A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand
Sodsai Tovanabutra, Veerachai Watanaveeradej, Kwanjai Viputtikul, et al.
The Journal of Infectious Diseases
|
February 25, 2016
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene
Robert J O'Connell, Jean-Louis Excler, Victoria R Polonis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
April 8, 2022
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019
Hendrik Streeck, Klaus Jansen, Trevor A Crowell, et al.
Plos One
|
May 22, 2026
HIV incidence among sexually active young males and females in Kisumu County, Western Kenya
John Owuoth, Chiaka Nwoga, Valentine Sing'oei, et al.
Ebiomedicine
|
January 20, 2015
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
Susan Zolla-Pazner, Paul T Edlefsen, Morgane Rolland, et al.
Plos One
|
December 30, 2011
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand
Punnee Pitisuttithum, Supachai Rerks-Ngarm, Valai Bussaratid, et al.
AIDS (London, England)
|
February 1, 2023
Brain volumetrics differ by Fiebig stage in acute HIV infection
Jacob Bolzenius, Carlo Sacdalan, Lishomwa C Ndhlovu, et al.
Page
of 74
Search research articles
Search
Showing results (571-580 of 731) with videos related to
Sort By:
Page
of 74
Plos One
|
May 19, 2016
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial
Agricola Joachim, Asli Bauer, Sarah Joseph, et al.
Plos Pathogens
|
August 4, 2016
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection
Korey R Demers, George Makedonas, Marcus Buggert, et al.
The Journal of Infectious Diseases
|
October 29, 2002
Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells
Mary A Marovich, John R Mascola, Michael A Eller, et al.
AIDS Research and Human Retroviruses
|
August 12, 2003
A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand
Sodsai Tovanabutra, Veerachai Watanaveeradej, Kwanjai Viputtikul, et al.
The Journal of Infectious Diseases
|
February 25, 2016
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene
Robert J O'Connell, Jean-Louis Excler, Victoria R Polonis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
April 8, 2022
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019
Hendrik Streeck, Klaus Jansen, Trevor A Crowell, et al.
Plos One
|
May 22, 2026
HIV incidence among sexually active young males and females in Kisumu County, Western Kenya
John Owuoth, Chiaka Nwoga, Valentine Sing'oei, et al.
Ebiomedicine
|
January 20, 2015
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
Susan Zolla-Pazner, Paul T Edlefsen, Morgane Rolland, et al.
Plos One
|
December 30, 2011
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand
Punnee Pitisuttithum, Supachai Rerks-Ngarm, Valai Bussaratid, et al.
AIDS (London, England)
|
February 1, 2023
Brain volumetrics differ by Fiebig stage in acute HIV infection
Jacob Bolzenius, Carlo Sacdalan, Lishomwa C Ndhlovu, et al.
Page
of 74